Get the Stockscreener App
5.36
3.28%
0.17
After Hours:
5.33
-0.03
-0.56%
Journey Medical Corp Stock (DERM) Forecast
The Journey Medical Corp (DERM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5382, representing a -89.96% decrease from the current price of $5.36. The highest analyst price target is $0.6209, and the lowest is $0.4555.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DERM Price Target
Average 1.3644
(-74.54% Downside)
Is Journey Medical Corp (DERM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.50 | Neutral |
| STOCH(9,6) | 61.15 | Neutral |
| STOCHRSI(14) | 50.07 | Neutral |
| MACD(12,26) | 0.2369 | Buy |
| ADX(14) | 25.63 | Buy |
| William %R | -21.59 | Neutral |
| CCI(14) | 20.03 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.179
Buy
|
5.1276
Buy
|
| MA20 |
4.888
Buy
|
4.9265
Buy
|
| MA50 |
4.5308
Buy
|
4.7827
Buy
|
| MA100 |
5.1186
Buy
|
4.8721
Buy
|
| MA200 |
4.9905
Buy
|
4.8604
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, DERM could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on DERM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.5 indicates that DERM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 61.15 indicates that DERM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.07 indicates that DERM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.63 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 20.03 indicates that DERM is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term DERM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Journey Medical Corp financial reports and earnings history, Journey Medical Corp (DERM) stock could reach $7.7039 by 2030, $18.40 by 2040 and $41.49 by 2050. See the projected annual prices until 2050 of the Journey Medical Corp stock below:
- Journey Medical Corp (DERM) is expected to reach an average price of $6.1111 in 2035, with a high prediction of $7.3034 and a low estimate of $6.4511. This indicates an $14.01% rise from the last recorded price of $5.36.
- Journey Medical Corp (DERM) stock is projected to chart a bullish course in 2040, with an average price target of $18.02, representing an $236.11% surge from its current level. The forecast ranges from a conservative $18.23 to a sky-high $18.40.
- Our analysts predict Journey Medical Corp (DERM) to jump 444.84% by 2045, soaring from $29.10 to an average price of $29.20, potentially reaching $28.94. While $29.10 is the low estimate, the potential upside is significant.
- Journey Medical Corp (DERM) stock is expected to climb by 2050, reaching an average of $42.09, a $685.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $41.49 and $41.60, respectively, highlighting the market's uncertainty.
Journey Medical Corp Stock (DERM) Year by Year Forecast
Journey Medical Corp Stock (DERM) Price Forecast for 2025
Journey Medical Corp Stock (DERM) is expected to reach an average price of $1.3644 in 2025, with a high prediction of $2.2733 and a low estimate of $0.4555. This indicates an -74.54% fall from the last recorded price of $5.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.6788 | $0.4555 | $0.6209 | -87.34% |
| April, 2025 | $1.5065 | $1.166 | $1.1765 | -71.89% |
| May, 2025 | $1.6171 | $1.4969 | $1.2667 | -69.83% |
| June, 2025 | $2.0576 | $1.6461 | $1.6368 | -61.61% |
| July, 2025 | $2.3082 | $1.928 | $1.9577 | -56.94% |
| August, 2025 | $1.0987 | $2.0857 | $2.2733 | -79.50% |
| September, 2025 | $1.0992 | $1.4989 | $1.2277 | -79.49% |
| October, 2025 | $1.8699 | $1.6095 | $1.6835 | -65.11% |
| November, 2025 | $1.8004 | $2.03 | $1.8004 | -66.41% |
| December, 2025 | $1.7211 | $1.7709 | $1.6807 | -67.89% |
Journey Medical Corp Stock (DERM) Price Forecast for 2026
The predicted value for Journey Medical Corp (DERM) in 2026 is set at an average of $2.8492. Estimates vary from a peak of $5.5941 to a trough of $0.1044, indicating an -46.84% surge from the present price of $5.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.9966 | $1.8109 | $1.8317 | -62.75% |
| February, 2026 | $1.2921 | $1.4521 | $1.9017 | -75.89% |
| March, 2026 | $1.2126 | $1.2826 | $1.1526 | -77.38% |
| April, 2026 | $0.8532 | $0.9332 | $1.1527 | -84.08% |
| May, 2026 | $0.0963 | $0.8253 | $0.7783 | -98.20% |
| June, 2026 | $0.1158 | $0.2241 | $0.3359 | -97.84% |
| July, 2026 | $0.7751 | $0.1044 | $0.9451 | -85.54% |
| August, 2026 | $1.6746 | $0.5208 | $3.1546 | -68.76% |
| September, 2026 | $3.264 | $1.4976 | $5.5941 | -39.11% |
| October, 2026 | $2.6234 | $2.1639 | $3.675 | -51.06% |
| November, 2026 | $1.9229 | $1.6632 | $2.8133 | -64.12% |
| December, 2026 | $1.1623 | $0.9863 | $2.0424 | -78.32% |
Journey Medical Corp Stock (DERM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Journey Medical Corp (DERM) is $2.8855, with a high forecast of $5.119 and a low forecast of $0.652. This indicates an -46.17% decrease from the last price of $5.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2618 | $0.652 | $2.4776 | -57.80% |
| February, 2027 | $1.709 | $1.1664 | $2.2516 | -68.12% |
| March, 2027 | $2.821 | $1.76 | $2.3733 | -47.37% |
| April, 2027 | $4.5321 | $4.1404 | $4.2718 | -15.45% |
| May, 2027 | $3.9431 | $4.3331 | $4.3184 | -26.44% |
| June, 2027 | $4.7644 | $4.3041 | $4.1891 | -11.11% |
| July, 2027 | $4.2954 | $4.5084 | $4.3649 | -19.86% |
| August, 2027 | $4.6264 | $4.3062 | $4.1656 | -13.69% |
| September, 2027 | $4.8177 | $5.1276 | $4.7769 | -10.12% |
| October, 2027 | $5.6887 | $5.0082 | $4.9469 | +6.13% |
| November, 2027 | $4.9598 | $5.1295 | $5.119 | -7.47% |
| December, 2027 | $4.391 | $4.581 | $4.76 | -18.08% |
Journey Medical Corp Stock (DERM) Price Forecast for 2028
In 2028, Journey Medical Corp (DERM) is projected to reach an average price of $5.2629, with a high projection of $5.9617 and a low estimate of $4.5641. This indicates an -1.81% fall from the last price of $5.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.0621 | $4.8313 | $4.6868 | -5.56% |
| February, 2028 | $5.4731 | $5.1826 | $5.1431 | +2.11% |
| March, 2028 | $5.4844 | $5.4039 | $5.2656 | +2.32% |
| April, 2028 | $5.8354 | $5.6548 | $5.7454 | +8.87% |
| May, 2028 | $6.1967 | $5.6759 | $5.9617 | +15.61% |
| June, 2028 | $4.8977 | $5.1077 | $5.4113 | -8.62% |
| July, 2028 | $4.9587 | $5.0485 | $4.7968 | -7.49% |
| August, 2028 | $5.41 | $5.119 | $5.1334 | +0.93% |
| September, 2028 | $5.2011 | $5.3011 | $5.1708 | -2.97% |
| October, 2028 | $4.9922 | $5.0618 | $5.0113 | -6.86% |
| November, 2028 | $5.0934 | $5.062 | $5.0734 | -4.97% |
| December, 2028 | $4.5944 | $4.5641 | $4.3437 | -14.28% |
Journey Medical Corp Stock (DERM) Price Forecast for 2029
The 2029 price forecast for Journey Medical Corp Stock (DERM) is $2.8667 on average, with a high prediction of $5.70 and a low estimate of $0.0334. This represents an -46.52% decrease from the previous price of $5.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.0557 | $4.1957 | $4.1852 | -24.33% |
| February, 2029 | $3.7667 | $3.8664 | $3.7859 | -29.73% |
| March, 2029 | $3.0077 | $3.2827 | $3.5872 | -43.89% |
| April, 2029 | $2.5188 | $2.8588 | $2.5281 | -53.01% |
| May, 2029 | $1.58 | $1.9498 | $2.219 | -70.52% |
| June, 2029 | $0.7511 | $1.078 | $1.0731 | -85.99% |
| July, 2029 | $0.7679 | $0.3979 | $3.0782 | -85.67% |
| August, 2029 | $0.0566 | $0.0334 | $1.1989 | -98.94% |
| September, 2029 | $0.9844 | $0.4741 | $0.4344 | -81.63% |
| October, 2029 | $1.1357 | $0.6949 | $0.7554 | -78.81% |
| November, 2029 | $0.7967 | $0.7165 | $0.3193 | -85.14% |
| December, 2029 | $6.45 | $0.7858 | $5.70 | +20.34% |
Journey Medical Corp Stock (DERM) Price Forecast for 2030
Journey Medical Corp Stock (DERM) is expected to reach an average price of $8.2419 in 2030, with a high forecast of $9.4035 and a low forecast of $7.0804. This signifies an +53.77% surge from the last price of $5.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.9419 | $7.0804 | $7.7039 | +66.83% |
| February, 2030 | $9.3835 | $9.4623 | $9.1127 | +75.06% |
| March, 2030 | $8.935 | $9.0746 | $9.0997 | +66.70% |
| April, 2030 | $9.4065 | $8.9662 | $8.8512 | +75.50% |
| May, 2030 | $8.7785 | $8.9085 | $8.9673 | +63.78% |
| June, 2030 | $9.54 | $8.8092 | $8.7792 | +77.99% |
| July, 2030 | $9.2219 | $9.4619 | $9.2204 | +72.05% |
| August, 2030 | $9.7235 | $9.3523 | $9.4035 | +81.41% |
| September, 2030 | $9.145 | $9.305 | $9.0539 | +70.62% |
| October, 2030 | $8.9369 | $8.7066 | $8.9254 | +66.73% |
| November, 2030 | $8.8885 | $9.2073 | $8.7527 | +65.83% |
| December, 2030 | $9.47 | $9.1693 | $9.16 | +76.68% |
0.92%
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):